CANESTRARI, EMANUELE
CANESTRARI, EMANUELE
C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC).
2011 Galluccio, N; Ruzzo, A; Canestrari, E; Lorenzini, P; D'Emidio, S; Sisti, V; Catalano, V; Andreoni, F; Zingaretti, C; De Nictolis, M; Ligorio, C; Cappuzzo, F; Magnani, M; Graziano, F
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
2010 F., Graziano; Canestrari, Emanuele; F., Loupakis; Ruzzo, Annamaria; N., Galluccio; D., Santini; Rocchi, MARCO BRUNO LUIGI; B., Vincenzi; L., Salvatore; C., Cremolini; C., Spoto; V., Catalano; S., D'Emidio; P., Giordani; G., Tonini; A., Falcone; Magnani, Mauro
High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene.
2009 Maltese, P; Canestrari, Emanuele; Palma, L; Ruzzo, Annamaria; Corini, F; Menotta, Michele; Andreoni, F; Latiano, A; Annese, V; Magnani, M.
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer
2009 Loupakis, Fotios; Pollina, Luca; Stasi, Irene; Ruzzo, Annamaria; Scartozzi, Mario; Santini, Daniele; Masi, Gianluca; Graziano, Francesco; Cremolini, Chiara; Rulli, Eliana; Canestrari, Emanuele; Funel, Niccola; Schiavon, Gaia; Petrini, Iacopo; Magnani, Mauro; Tonini, Giuseppe; Campani, Daniela; Floriani, Irene; Cascinu, Stefano; Falcone, Alfredo
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.
2009 Loupakis, F; Pollina, L; Stasi, I; Ruzzo, Annamaria; Scartozzi, M; Santini, D; Masi, G; Graziano, F; Cremolini, C; Rulli, E; Canestrari, Emanuele; Funel, N; Schiavon, G; Petrini, I; Magnani, M; Tonini, G; Campani, D; Floriani, I; Cascinu, S; Falcone, A.
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.
2009 Graziano, F; Ruzzo, Annamaria; Canestrari, Emanuele; Loupakis, F; Santini, D; Rulli, E; Humar, B; Galluccio, N; Bisonni, R; Floriani, I; Maltese, P; Falcone, A; Tonini, G; Catalano, V; Fontana, A; Giustini, L; Masi, G; Vincenzi, B; Alessandroni, P; Magnani, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC). | 1-gen-2011 | Galluccio, N; Ruzzo, A; Canestrari, E; Lorenzini, P; D'Emidio, S; Sisti, V; Catalano, V; Andreoni, F; Zingaretti, C; De Nictolis, M; Ligorio, C; Cappuzzo, F; Magnani, M; Graziano, F | |
| Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan | 1-gen-2010 | F., Graziano; Canestrari, Emanuele; F., Loupakis; Ruzzo, Annamaria; N., Galluccio; D., Santini; Rocchi, MARCO BRUNO LUIGI; B., Vincenzi; L., Salvatore; C., Cremolini; C., Spoto; V., Catalano; S., D'Emidio; P., Giordani; G., Tonini; A., Falcone; Magnani, Mauro | |
| High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene. | 1-gen-2009 | Maltese, P; Canestrari, Emanuele; Palma, L; Ruzzo, Annamaria; Corini, F; Menotta, Michele; Andreoni, F; Latiano, A; Annese, V; Magnani, M. | |
| PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer | 1-gen-2009 | Loupakis, Fotios; Pollina, Luca; Stasi, Irene; Ruzzo, Annamaria; Scartozzi, Mario; Santini, Daniele; Masi, Gianluca; Graziano, Francesco; Cremolini, Chiara; Rulli, Eliana; Canestrari, Emanuele; Funel, Niccola; Schiavon, Gaia; Petrini, Iacopo; Magnani, Mauro; Tonini, Giuseppe; Campani, Daniela; Floriani, Irene; Cascinu, Stefano; Falcone, Alfredo | |
| PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. | 1-gen-2009 | Loupakis, F; Pollina, L; Stasi, I; Ruzzo, Annamaria; Scartozzi, M; Santini, D; Masi, G; Graziano, F; Cremolini, C; Rulli, E; Canestrari, Emanuele; Funel, N; Schiavon, G; Petrini, I; Magnani, M; Tonini, G; Campani, D; Floriani, I; Cascinu, S; Falcone, A. | |
| Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. | 1-gen-2009 | Graziano, F; Ruzzo, Annamaria; Canestrari, Emanuele; Loupakis, F; Santini, D; Rulli, E; Humar, B; Galluccio, N; Bisonni, R; Floriani, I; Maltese, P; Falcone, A; Tonini, G; Catalano, V; Fontana, A; Giustini, L; Masi, G; Vincenzi, B; Alessandroni, P; Magnani, M. |